Your browser doesn't support javascript.
loading
Limited Sustained Local Transmission of HIV-1 CRF01_AE in New South Wales, Australia.
Di Giallonardo, Francesca; Pinto, Angie N; Keen, Phillip; Shaik, Ansari; Carrera, Alex; Salem, Hanan; Telfer, Barbara; Cooper, Craig; Price, Karen; Selvey, Christine; Holden, Joanne; Bachmann, Nadine; Lee, Frederick J; Dwyer, Dominic E; Duchêne, Sebastián; Holmes, Edward C; Grulich, Andrew E; Kelleher, Anthony D.
Afiliação
  • Di Giallonardo F; The Kirby Institute, The University of New South Wales, Sydney, New South Wales 2052, Australia. fdigiallonardo@kirby.unsw.edu.au.
  • Pinto AN; The Kirby Institute, The University of New South Wales, Sydney, New South Wales 2052, Australia. apinto@kirby.unsw.edu.au.
  • Keen P; Department of Infectious Diseases & Microbiology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2050, Australia. apinto@kirby.unsw.edu.au.
  • Shaik A; The Kirby Institute, The University of New South Wales, Sydney, New South Wales 2052, Australia. pkeen@kirby.unsw.edu.au.
  • Carrera A; The Kirby Institute, The University of New South Wales, Sydney, New South Wales 2052, Australia. ashaik@kirby.unsw.edu.au.
  • Salem H; New South Wales State Reference Laboratory for HIV/AIDS, Darlinghurst, New South Wales 2010, Australia. alex.carrera@svha.org.au.
  • Telfer B; New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2050, Australia. hanan.salem@health.nsw.gov.au.
  • Cooper C; Health Protection New South Wales, New South Wales Health, NSW, North Sydne, New South Wales 2060, Australia. barbara.telfer@health.nsw.gov.au.
  • Price K; Positive Life New South Wales, Surry Hills, New South Wales 2010, Australia. craigc@positivelife.org.au.
  • Selvey C; ACON Health Ltd., Surry Hills, New South Wales 2010, Australia. kprice@acon.org.au.
  • Holden J; Health Protection New South Wales, New South Wales Health, NSW, North Sydne, New South Wales 2060, Australia. christine.selvey@health.nsw.gov.au.
  • Bachmann N; Centre for Population Health, New South Wales Ministry of Health, North Sydney, New South Wales 2059, Australia. jo.holden@health.nsw.gov.au.
  • Lee FJ; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Institute of Medical Virology, University of Zurich, 8091 Zurich, Switzerland. nadine.bachmann2@usz.ch.
  • Dwyer DE; New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2050, Australia. frederick.lee@health.nsw.gov.au.
  • Duchêne S; Department of Clinical Immunology & Allergy, Royal Prince Alfred Hospital, Camperdown, New South Wales 2050, Australia. frederick.lee@health.nsw.gov.au.
  • Holmes EC; Sydney Medical School, University of Sydney, Sydney, New South Wales 2006, Australia. frederick.lee@health.nsw.gov.au.
  • Grulich AE; New South Wales Health Pathology-Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, New South Wales 2145, Australia. dominic.dwyer@sydney.edu.au.
  • Kelleher AD; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria 3000, Australia. sebastian.duchene@unimelb.edu.au.
Viruses ; 11(5)2019 05 27.
Article em En | MEDLINE | ID: mdl-31137836
ABSTRACT
Australia's response to the human immunodeficiency virus type 1 (HIV-1) pandemic led to effective control of HIV transmission and one of the world's lowest HIV incidence rates-0.14%. Although there has been a recent decline in new HIV diagnoses in New South Wales (NSW), the most populous state in Australia, there has been a concomitant increase with non-B subtype infections, particularly for the HIV-1 circulating recombinant form CRF01_AE. This aforementioned CRF01_AE sampled in NSW, were combined with those sampled globally to identify NSW-specific viral clades. The population growth of these clades was assessed in two-year period intervals from 2009 to 2017. Overall, 109 NSW-specific clades were identified, most comprising pairs of sequences; however, five large clades comprising ≥10 sequences were also found. Forty-four clades grew over time with one or two sequences added to each in different two-year periods. Importantly, while 10 of these clades have seemingly discontinued, the remaining 34 were still active in 2016/2017. Seven such clades each comprised ≥10 sequences, and are representative of individual sub-epidemics in NSW. Thus, although the majority of new CRF01_AE infections were associated with small clades that rarely establish ongoing chains of local transmission, individual sub-epidemics are present and should be closely monitored.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 Limite: Humans País como assunto: Oceania Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 Limite: Humans País como assunto: Oceania Idioma: En Ano de publicação: 2019 Tipo de documento: Article